Arnie Pye
Senior Member (Voting Rights)
the sim with the number
What is a sim?
the sim with the number
I have read that flu vaccine for over 75s ( which I wish to take- have had flu vaccine every year for ever) is differently constituted from that given to under 75s. Can anyone confirm this? I have concerns that it may be an MRNA. Mr B had his this morning but no one at the doctor's surgery where it was given was able to advise on this.
What is a sim?
I’m in such fear of this.It's the tiny card you put in a mobile phone, which has the subscriber's phone number and various other data on it. Without that info, the mobile won't work.
You can transfer the same SIM card from one phone to another, which transfers the phone number over as well. I had to do that when I absent-mindedly put my mobile through a 40º wash cycle—phone was knackered, but the card was fine.
It's the tiny card you put in a mobile phone, which has the subscriber's phone number and various other data on it. Without that info, the mobile won't work.
You can transfer the same SIM card from one phone to another, which transfers the phone number over as well. I had to do that when I absent-mindedly put my mobile through a 40º wash cycle—phone was knackered, but the card was fine.
I spent a while wondering why you had a personal assistant, and whether I had missed the fact that you were a high-flying CEO.I was only aware of this because we tried to organise that my pa and I had the vaccine at the same time
I spent a while wondering why you had a personal assistant, and whether I had missed the fact that you were a high-flying CEO.
The NHS website said I wasn't eligible for a free Covid vaccination, so I booked a private one for today. But the pharmacy's system said I was on the free list, and so was my husband as a carer. I'm not going to try to understand it but am happy with the outcome!
Editor’s summary
mRNA vaccines for SARS-CoV-2 elicit robust antibody responses in the circulation, which aid in protection from severe disease. However, the extent to which mRNA vaccines, which are delivered intramuscularly, can elicit mucosal immune responses is unclear. In a pair of papers, Declercq et al. and Lasrado et al. come to distinct conclusions. Using human nasal swab samples in both studies, Declercq et al. show that repeated vaccination for SARS-CoV-2 promotes neutralizing antibodies in the nose, whereas Lasrado et al. observed no obvious increase in neutralizing antibody titers after booster vaccination. These differing results may be due to the number of SARS-CoV-2 vaccinations or exposures, time since last exposure, and experimental approaches, but this pair of papers underscores the need to better understand the mucosal immune response in humans. —Courtney Malo
Abstract
Introduction
Post-COVID-19 conditions have emerged as a global health challenge. This study examined the long-term effects of COVID-19 vaccination on the incidence and risk of post-COVID-19 conditions in Japan.
Methods
This retrospective cohort study was conducted using a database comprising medical claims, COVID-19 case information, and vaccination records of persons residing in four Japanese municipalities. The cohort included COVID-19 cases diagnosed between August 2020 and December 2022. Participants were classified according to the duration between their most recent COVID-19 vaccination and COVID-19 occurrence (≥365 days, 150–364 days, and 14–149 days). The incidences of 36 post-COVID-19 conditions were monitored for 3, 5, and 8 months after infection. Cox proportional hazards models were used to calculate the risk of developing each post-COVID-19 condition within 8 months after infection according to vaccination status.
Results
From among 84,464 participants, 9642 (11.4 %) developed post-COVID-19 conditions over 8 months. The 8-month risks of developing 28 (including various respiratory conditions, cardiovascular conditions, inflammatory and immune diseases, physical conditions, psychiatric conditions, and endocrine disorders) of the 36 target conditions were significantly lower when individuals had been recently vaccinated (14–149 days) before infection.
Conclusions
COVID-19 vaccination can reduce the incidence and risk of post-COVID-19 conditions if administered within 5 months before infection. Despite having the highest mean age and prevalence of comorbidities, individuals who were most recently vaccinated had a lower risk of developing post-COVID-19 conditions. These results provide important evidence for future COVID-19 vaccination strategies.
they've got me listed as having 17 vaccines![]()